US2012134917A1PendingUtilityA1
Dermatological composition
Est. expiryAug 18, 2020(expired)· nominal 20-yr term from priority
A61P 39/00A61P 17/14A61P 17/08Y10T428/2982A61P 17/00A61P 17/02A61Q 19/00A61K 2800/56A61K 33/00A61P 17/16A61P 17/10A61K 8/25A61P 17/06A61Q 17/04
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Dermatological methods of cosmetic, therapeutic, prophylactic, and/or diagnostic treatment by topically applying compositions comprising a multiplicity of particles, at least one of the particles comprising porous and/or polycrystalline silicon. Included are methods and compositions for sun protection applications. The use of porous silicon, polycrystalline silicon, and porous silicon oxide mirrors is disclosed.
Claims
exact text as granted — not AI-modified1 .- 13 . (canceled)
14 . A method of protecting the skin or a human or animal from UV radiation comprising the step of topically applying a dermatological composition comprising a plurality of particles comprising polycrystalline silicon.
15 . A method according to claim 14 wherein the polycrystalline silicon has a particle size in a range of 0.01 to 250 μm.
16 . A method according to claim 14 wherein the composition comprises a dermatologically acceptable carrier.
17 . A method according to claim 14 wherein the polycrystalline silicon is resorbable.
18 . A method according to claim 14 wherein the composition comprises a plurality of mirrors made from a plurality of layers of polycrystalline silicon, each mirror comprising a plurality of layers, each layer comprising polycrystalline silicon.
19 . A method according to claim 18 wherein the composition comprises a plurality of groups of mirrors, each group reflecting radiation over a wavelength range that differs from that of the other groups.
20 . A method according to claim 14 wherein the composition further comprises at least one beneficial substance.
21 . A method according to claim 20 wherein the at least one beneficial substance is selected from the group consisting of a biological material, a genetic material, a radioactive material, an antibacterial and a luminescent material.
22 . A method according to claim 14 wherein the polycrystalline silicon is present in the form of polycrystalline silicon oxide.
23 . A dermatological composition comprising a multiplicity of particles, each particle comprising polycrystalline silicon.
24 . A dermatological composition according to claim 23 wherein the polycrystalline silicon has a particle size in a range of 0.01 to 250 μm.
25 . A dermatological composition according to claim 23 wherein the composition comprises a dermatologically acceptable carrier.
26 . A dermatological composition according to claim 23 wherein the polycrystalline silicon is resorbable.
27 . A dermatological composition according to claim 23 wherein the composition comprises a plurality of mirrors made from a plurality of layers of polycrystalline silicon, each mirror comprising a plurality of layers, each layer comprising polycrystalline silicon.
28 . A dermatological composition according to claim 23 wherein the composition comprises a plurality of groups of mirrors, each group reflecting radiation over a wavelength range that differs from that of the other groups.
29 . A dermatological composition according to claim 23 wherein the composition further comprises at least one beneficial substance.
30 . A dermatological composition according to claim 29 wherein the at least one beneficial substance is selected from the group consisting of a biological material, a genetic material, a radioactive material, an antibacterial and a luminescent material.
31 . A dermatological composition according to claim 23 wherein the polycrystalline silicon is present in the form of polycrystalline silicon oxide.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.